Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study of Efficacy and Safety With the Transdermal Contraceptive System Versus Triphasil.
This study has been completed.
Study NCT00236795   Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
First Received: October 7, 2005   Last Updated: May 11, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Female Contraception
Contraception
Additional drug interventions recognized in this trial
Contraceptive Agents
Estradiol
Estradiol 17 beta-cypionate
Estradiol 3-benzoate
Estradiol valerate
Ethinyl Estradiol
Ethinyl Estradiol-Norgestrel Combination
Norelgestromin
Polyestradiol phosphate
More general drug interventions related to this trial
Contraceptive Agents, Female
Contraceptives, Oral
Contraceptives, Oral, Combined
Contraceptives, Oral, Synthetic
Contraceptives, Postcoital
Contraceptives, Postcoital, Synthetic
Estrogens
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Pharmacologic Actions
Physiological Effects of Drugs
Reproductive Control Agents
Therapeutic Uses
Sponsors listed in this trial
Johnson &Johnson Pharmaceutical Research &Development, L.L.C.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services